Abivax Stock Quote ABVX - Stock Price, News, Charts, Message Board, Trades

Register to chat with like-minded investors on our interactive forums.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Abivax SA (ABVX) Quote

Abivax SA (ABVX)

13.07

-0.43

(-3.19%)

Closed July 03 4:00PM

Delayed by 15 minutes

13.07

0.00

(0.00%)

After Hours: 5:00PM

Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Current Price

13.07

Bid

10.00

Ask

21.28

Volume

8,262

13.03 Day's Range 13.54

0.00 52 Week Range 0.00

Market Cap

Previous Close

13.50

Open

13.54

Last Trade

Last Trade Time

Financial Volume

$ 109,309

VWAP

13.2303

Average Volume (3m)

-

Shares Outstanding

62,917,479

Dividend Yield

-

PE Ratio

-5.38

Earnings Per Share (EPS)

-2.35

Revenue

4.62M

Net Profit

-147.74M

Abivax is focused on developing innovative treatments that harness the body¿s natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases. Abivax is focused on developing innovative treatments that harness the body¿s natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases.

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.abivax.com

Headquarters

Paris, Paris, Fra

Founded

1970

Abivax SA is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ABVX. The last closing price for Abivax was $13.50. Over the last year, Abivax shares have traded in a share price range of $ 0.00 to $ 0.00.

Abivax currently has 62,917,479 shares outstanding. The market capitalization of Abivax is $795.28 million. Abivax has a price to earnings ratio (PE ratio) of -5.38.

FeaturedFreedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Abivax releases the results of its May 30, 2024 Ordinary and Extraordinary General Meeting

PARIS, France, June 4, 2024 – Abivax SA (Euronext Paris & Nasdaq: ABVX) (“Abivax” or the “Company”), a clinical-stage biotechnology company focused on developing therapeutics that harness the...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	DR
4	0	0	0	0	0	0	0	DR
12	0	0	0	0	0	0	0	DR
26	0	0	0	0	0	0	0	DR
52	0	0	0	0	0	0	0	DR
156	0	0	0	0	0	0	0	DR
260	0	0	0	0	0	0	0	DR

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
KOSSKoss Corporation	$ 10.63 (143.81%)	70.06M
JEWLAdamas One Corporation	$ 0.4615 (89.14%)	6.58M
VVPRVivoPower International PLC	$ 2.50 (66.67%)	55.79M
DOYUDouYu International Holdings Ltd	$ 17.94 (42.49%)	5.25M
AHGAkso Health Group	$ 1.155 (40.51%)	520k
SHPWShapeways Holdings Inc	$ 0.2693 (-61.86%)	1.99M
SONMSonim Technologies Inc	$ 0.5507 (-42.34%)	1.47M
SHOTWSafety Shot Inc	$ 0.18 (-35.71%)	2.01k
AMIXAutonomix Medical Inc	$ 0.6415 (-31.76%)	19.59M
VIVKVivakor Inc	$ 2.31 (-31.66%)	368.29k
NVDANVIDIA Corporation	$ 128.28 (4.57%)	215.8M
ZCARZoomcar Holdings Inc	$ 0.183 (33.97%)	204.3M
MAXNMaxeon Solar Technologies Ltd	$ 0.1736 (-3.50%)	202.28M
TSLATesla Inc	$ 246.39 (6.54%)	166.56M
TSLLDirexion Daily TSLA Bull 2X Trust ETF	$ 14.02 (13.16%)	86.38M

100lbStriper

100lbStriper 4 minutes ago

Netlist's Demonstrative for Oral Argument in IPR of claim 16 of 912 ptnt.
https://ptacts.uspto.gov/ptacts/public-informations/petitions/1549198/download-documents?artifactId=iV6bZqJApakGi2fiTj84DgvMiHwMmkHmcr0cp-EGZ4acs15KC4matgw

tutt1126

tutt1126 4 minutes ago

U.s. debt is now at about $ 34 trillion.
Powell warned that it's unsustainable.

SILVERSURFER4263

SILVERSURFER4263 5 minutes ago

https://www.epa.gov/iaq-schools/healthy-indoor-environments-schools-plans-practices-and-principles-maintaining-healthy

Bubae

Bubae 5 minutes ago

Like to see a link to that information. There are no bounds for you in promoting this trash is there? What does it pay these days to promote or did you really buy into this walk up?

SILVERSURFER4263

SILVERSURFER4263 5 minutes ago

only a anti child pos would not want to see vxit/maxclean succeed

dewophile

dewophile 6 minutes ago

“As it is, the study in the JAMA paper was retrospective and observational, so it’s reasonable to be skeptical of the findings. “

I concur with your comment but would also add that while I don’t see mechanistically why GLP-1 agonists should increase the risk of this disorder there is

Fdc4

Fdc4 6 minutes ago

We all have done that, don’t punish yourself over it, since it will take you nowhere. Besides, there was no way, you could be certain of making the right move at early stage over SMCE. Anyways, you are back and that’s what matters. I haven’t gotten in yet because of the constant spike, it must come

SILVERSURFER4263

SILVERSURFER4263 6 minutes ago

https://www.lung.org/clean-air/indoor-air/building-type-air-resources/at-school

crazy horse 0

crazy horse 0 6 minutes ago

A problem you think

https://scontent-mia3-2.xx.fbcdn.net/v/t39.30808-6/449782854_10230420357665705_4036826649681873020_n.jpg?_nc_cat=102&ccb=1-7&_nc_sid=aa7b47&_nc_ohc=RExQIaDD0nEQ7kNvgHaAhb7&_nc_ht=scontent-mia3-2.xx&oh=00_AYAS1Usy4ZvH_0gyNCJGH6pJKf6Pla0Q5ka6BoL8WyWOeQ&oe=668BCA98

SILVERSURFER4263

SILVERSURFER4263 6 minutes ago

Biden-Harris administration announces availability of $32M in grant funding to tackle air pollution at schools and deliver cleaner air for America’s children
January 11, 2024

Contact Information
EPA Press Office (press@epa.gov)
WASHINGTON – The U.S. Environmental

The ELTP King

The ELTP King 6 minutes ago

Wrong.

No waiting required.

Elite already has an approved vault in their old facility.

However, I actually do think they're going to wait a bit to launch the three drugs they acquired.

Here's why:

Nasrat stated in the CC he

SILVERSURFER4263

SILVERSURFER4263 7 minutes ago

https://www.epa.gov/newsreleases/biden-harris-administration-announces-availability-32m-grant-funding-tackle-air

rooster

rooster 7 minutes ago

I see us losing right now. So no your logic is wrong. America will get back to winning under the Trumpster once again

SILVERSURFER4263

SILVERSURFER4263 7 minutes ago

https://virexittechnologies.com/

SILVERSURFER4263

SILVERSURFER4263 8 minutes ago

https://x.com/OfficialVXIT/status/1808496891350360159

brinfin

brinfin 8 minutes ago

Absolutely true, No 2s for retail. Good news is that with any substantial closings or fundings the Ask will be very thin and the stock will move upward very quickly. IMO

arizona1

arizona1 8 minutes ago

https://x.com/RebekahWriter/status/1807224261502796236

100lbStriper

100lbStriper 9 minutes ago

Stokd $NLST Just adding to conversation—from Netlist's Demonstrative.

All of Petitioners' Grounds Are Deficient
-Ellsberry is not printed publication (similar
issue now before the Federal Circuit)
-Ellsberry is not Prior Art: Ellsberry was filed
Jun 1

surfkast

surfkast 10 minutes ago

Nobody needs you to think for them.
Then stop posting Hopium! LOL

arizona1

arizona1 11 minutes ago

Unsurprisingly John Mac Ghlionn locked his Twitter account.

Shame on @Newsweek & writer John Mac Ghlionn. Their 'hot take' on why #TaylorSwift is not a role model is misogynistic, sexist & frankly idiotic ...

Number of times they have written about 34-year-old unmarr

100lbStriper

100lbStriper 11 minutes ago

SilviaJ $NLST Well, as we have been discussing, there IS objective evidence that Ellsberry is NOT prior art.

"Patent Owner does not present objective evidence of non-obviousness other than to respond to Petitioner’s assertion of evidence of “simultaneous invention.”

LORTAP KCOTS

LORTAP KCOTS 12 minutes ago

Yes but over $3

Delayed Upgrade Clock